An Exploratory, Randomised, Double-blind, Placebo-controlled, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food-effect of TRK-750 in Healthy Adults and Patients With Peripheral Neuropathic Pain
Latest Information Update: 27 Dec 2018
At a glance
- Drugs TRK 750 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions
- Sponsors Toray Industries
- 17 Dec 2018 Status changed from recruiting to completed.
- 22 Nov 2017 New trial record